|
1
|
Abu-Elmagd M, Assidi M, Alrefaei AF and
Rebai A: Editorial: Advances in genomic and genetic tools, and
their applications for understanding embryonic development and
human diseases. Front Cell Dev Biol. 10:10164002022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
World Health Organization, . Global status
report on noncommunicable diseases 2010, 2010. https://www.who.int/nmh/publications/ncd_report_full_en.pdf
|
|
3
|
World Health Organization, . Fact sheets
2018, 2018. https://www.who.int/news-room/factsheets/detail/cancer
|
|
4
|
Alqahtani WS, Almufareh NA, Domiaty DM,
Albasher G, Alduwish MA, Alkhalaf H, Almuzzaini B, Al-Marshidy SS,
Alfraihi R, Elasbali AM, et al: Epidemiology of cancer in Saudi
Arabia thru 2010–2019: A systematic review with constrained
meta-analysis. AIMS Public Health. 7:679–696. 2020.PubMed/NCBI
|
|
5
|
Unger-Saldaña K: Challenges to the early
diagnosis and treatment of breast cancer in developing countries.
World J Clin Oncol. 5:465–477. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barrios CH: Global challenges in breast
cancer detection and treatment. Breast. 62 (Suppl 1):S3–S6. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
World Health Organization, . Cancer
control: Knowledge into action: WHO guide for effective programmes:
Module 3: Early detection. Geneva: World Health Organization;
2007
|
|
8
|
Song K and Farzaneh M: Signaling pathways
governing breast cancer stem cells behavior. Stem Cell Res Ther.
12:2452021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yousefnia S, Seyed Forootan F, Seyed
Forootan S, Nasr Esfahani MH, Gure AO and Ghaedi K: Mechanistic
pathways of malignancy in breast cancer stem cells. Front Oncol.
10:4522020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu X, Zhang M, Xu F and Jiang S: Wnt
signaling in breast cancer: Biological mechanisms, challenges and
opportunities. Mol Cancer. 19:1652020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kontomanolis EN, Kalagasidou S, Pouliliou
S, Anthoulaki X, Georgiou N, Papamanolis V and Fasoulakis ZN: The
notch pathway in breast cancer progression.
TScientificWorldJournal. 2018:24154892018.
|
|
12
|
Arnold SF, Tims E and McGrath BE:
Identification of bone morphogenetic proteins and their receptors
in human breast cancer cell lines: Importance of BMP2. Cytokine.
11:1031–1037. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Furth PA: STAT signaling in different
breast cancer sub-types. Mol Cell Endocrinol. 382:612–615. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yip CH and Rhodes A: Estrogen and
progesterone receptors in breast cancer. Future Oncol.
10:2293–2301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krishnamurti U and Silverman JF: HER2 in
breast cancer: A review and update. Adv Anat Pathol. 21:100–107.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mirzoeva OK, Das D, Heiser LM,
Bhattacharya S, Siwak D, Gendelman R, Bayani N, Wang NJ, Neve RM,
Guan Y, et al: Basal subtype and MAPK/ERK kinase
(MEK)-phosphoinositide 3-kinase feedback signaling determine
susceptibility of breast cancer cells to MEK inhibition. Cancer
Res. 69:565–572. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mohapatra P, Preet R, Das D, Satapathy SR,
Siddharth S, Choudhuri T, Wyatt MD and Kundu CN: The contribution
of heavy metals in cigarette smoke condensate to malignant
transformation of breast epithelial cells and in vivo initiation of
neoplasia through induction of a PI3K-AKT-NFκB cascade. Toxicol
Appl Pharmacol. 274:168–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu X, Zhang L, He X, Zhang P, Sun C, Xu X,
Lu Y and Li F: TGF-β plays a vital role in triple-negative breast
cancer (TNBC) drug-resistance through regulating stemness, EMT and
apoptosis. Biochem Biophys Res Commun. 502:160–165. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bhateja P, Cherian M, Majumder S and
Ramaswamy B: The Hedgehog signaling pathway: A viable target in
breast cancer? Cancers (Basel). 11:11262019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu L and Yang X: Targeting the hippo
pathway for breast cancer therapy. Cancers (Basel). 10:4222018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bhatelia K, Singh K and Singh R: TLRs:
Linking inflammation and breast cancer. Cell Signal. 26:2350–2357.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
González-Reyes S, Marín L, González L,
González LO, del Casar JM, Lamelas ML, González-Quintana JM and
Vizoso FJ: Study of TLR3, TLR4 and TLR9 in breast carcinomas and
their association with metastasis. BMC Cancer. 10:6652010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roychowdhury A, Jondhale M, Saldanha E,
Ghosh D, Kumar Panda C, Chandrani P and Mukherjee N: Landscape of
toll-like receptors expression in tumor microenvironment of triple
negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
Gene. 792:1457282021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niu T, Zhang W and Xiao W: MicroRNA
regulation of cancer stem cells in the pathogenesis of breast
cancer. Cancer Cell Int. 21:312021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taciak B, Pruszynska I, Kiraga L, Bialasek
M and Krol M: Wnt signaling pathway in development and cancer. J
Physiol Pharmacol. 69:2018.PubMed/NCBI
|
|
26
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yin P, Wang W, Zhang Z, Bai Y, Gao J and
Zhao C: Wnt signaling in human and mouse breast cancer: Focusing on
Wnt ligands, receptors and antagonists. Cancer Sci. 109:3368–3375.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang X, Zhang R, Hou C, He R, Wang QS,
Zhou TH, Li XQ, Zhai QL and Feng YM: FOXF2 oppositely regulates
stemness in luminal and basal-like breast cancer cells through the
Wnt/beta-catenin pathway. J Biol Chem. 298:1020822022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang C, Ye Z, Wan J, Liang J, Liu M, Xu X
and Li L: Secreted frizzled-related protein 2 is associated with
disease progression and poor prognosis in breast cancer. Dis
Markers. 2019:61493812019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Klopocki E, Kristiansen G, Wild PJ, Klaman
I, Castanos-Velez E, Singer G, Stöhr R, Simon R, Sauter G, Leibiger
H, et al: Loss of SFRP1 is associated with breast cancer
progression and poor prognosis in early stage tumors. Int J Oncol.
25:641–649. 2004.PubMed/NCBI
|
|
32
|
Saitoh T, Hirai M and Katoh M: Molecular
cloning and characterization of human frizzled-8 gene on chromosome
10p11.2. Int J Oncol. 18:991–996. 2001.PubMed/NCBI
|
|
33
|
Yin S, Xu L, Bonfil RD, Banerjee S, Sarkar
FH, Sethi S and Reddy KB: Tumor-initiating cells and FZD8 play a
major role in drug resistance in triple-negative breast cancer. Mol
Cancer Ther. 12:491–498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen W, Liu Z, Mai W, Xiao Y, You X and
Qin L: FZD8 indicates a poor prognosis and promotes gastric cancer
invasion and metastasis via B-catenin signaling pathway. Ann Clin
Lab Sci. 50:13–23. 2020.PubMed/NCBI
|
|
35
|
Li Q, Ye L, Zhang X, Wang M, Lin C, Huang
S, Guo W, Lai Y, Du H, Li J, et al: FZD8, a target of p53, promotes
bone metastasis in prostate cancer by activating canonical
Wnt/β-catenin signaling. Cancer Lett. 402:166–176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Murillo-Garzón V, Gorroño-Etxebarria I,
Åkerfelt M, Puustinen MC, Sistonen L, Nees M, Carton J, Waxman J
and Kypta RM: Frizzled-8 integrates Wnt-11 and transforming growth
factor-β signaling in prostate cancer. Nat Commun. 9:17472018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang K, Li Y, Wang J, Chen R and Li J: A
novel 12-gene signature as independent prognostic model in stage IA
and IB lung squamous cell carcinoma patients. Clin Transl Oncol.
23:2368–2381. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang Q, He M, Guan S, Ma M, Wu H, Yu Z,
Jiang L, Wang Y, Zong X, Jin F and Wei M: MicroRNA-100 suppresses
the migration and invasion of breast cancer cells by targeting
FZD-8 and inhibiting Wnt/β-catenin signaling pathway. Tumour Biol.
37:5001–5011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
World Medical Association, . World medical
association declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Schauer A, Korabiowska M, Kellner S,
Schumacher M, Sauer R, Bojar H and Rauschecker H: Grading system
for breast cancer. Anticancer Res. 18:2139–2144. 1998.PubMed/NCBI
|
|
41
|
Al-Maghrabi J, Emam E, Gomaa W, Saggaf M,
Buhmeida A, Al-Qahtani M and Al-Ahwal M: c-MET immunostaining in
colorectal carcinoma is associated with local disease recurrence.
BMC Cancer. 15:6762015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nedjadi T, Al-Maghrabi J, Assidi M, Dallol
A, Al-Kattabi H, Chaudhary A, Al-Sayyad A, Al-Ammari A, Abuzenadah
A, Buhmeida A and Al-Qahtani M: Prognostic value of HER2 status in
bladder transitional cell carcinoma revealed by both IHC and BDISH
techniques. BMC Cancer. 16:6532016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lipponen PK and Collan Y: Simple
quantitation of immunohistochemical staining positivity in
microscopy for histopathology routine. Acta Stereol. 11:125–132.
1992.
|
|
44
|
Buhmeida A, Elzagheid A, Algars A, Collan
Y, Syrjänen K and Pyrhönen S: Expression of the cell-cell adhesion
molecule beta-catenin in colorectal carcinomas and their
metastases. APMIS. 116:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lipponen P and Collan Y: Simple
quantitation of immuno-histochemical staining positivity in
microscopy. Acta Stereol. 11:125–132. 1992.
|
|
46
|
Maubant S, Tesson B, Maire V, Ye M,
Rigaill G, Gentien D, Cruzalegui F, Tucker GC, Roman-Roman S and
Dubois T: Transcriptome analysis of Wnt3a-treated triple-negative
breast cancer cells. PLoS One. 10:e01223332015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Maire V, Baldeyron C, Richardson M, Tesson
B, Vincent-Salomon A, Gravier E, Marty-Prouvost B, De Koning L,
Rigaill G, Dumont A, et al: TTK/hMPS1 is an attractive therapeutic
target for triple-negative breast cancer. PLoS One. 8:e637122013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pushparaj PN, Kalamegam G, Wali Sait KH
and Rasool M: Decoding the role of astrocytes in the entorhinal
cortex in Alzheimer's disease using high-dimensional single-nucleus
RNA sequencing data and next-generation knowledge discovery
methodologies: Focus on drugs and natural product remedies for
dementia. Front Pharmacol. 12:7201702022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Quillet A, Saad C, Ferry G, Anouar Y,
Vergne N, Lecroq T and Dubessy C: Improving bioinformatics
prediction of microRNA targets by ranks aggregation. Front Genet.
10:13302020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
AlSaleh KA: Efficacy of breast cancer
screening program in Kingdom of Saudi Arabia. Saudi Med J.
43:428–430. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Katoh M: Networking of WNT, FGF, Notch,
BMP, and Hedgehog signaling pathways during carcinogenesis. Stem
Cell Rev. 3:30–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Oakes SR, Gallego-Ortega D and Ormandy CJ:
The mammary cellular hierarchy and breast cancer. Cell Mol Life
Sci. 71:4301–4324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kendrick H, Regan JL, Magnay FA,
Grigoriadis A, Mitsopoulos C, Zvelebil M and Smalley MJ:
Transcriptome analysis of mammary epithelial subpopulations
identifies novel determinants of lineage commitment and cell fate.
BMC Genomics. 9:5912008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Alexander CM, Goel S, Fakhraldeen SA and
Kim S: Wnt signaling in mammary glands: Plastic cell fates and
combinatorial signaling. Cold Spring Harb Perspect Biol.
4:a0080372012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang HQ, Xu ML, Ma J, Zhang Y and Xie CH:
Frizzled-8 as a putative therapeutic target in human lung cancer.
Biochem Biophys Res Commun. 417:62–66. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Salsano E, Paterra R, Figus M, Menghi F,
Maderna E, Pollo B, Solero CL, Massimi L and Finocchiaro G:
Expression profile of frizzled receptors in human medulloblastomas.
J Neurooncol. 106:271–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang Q, Wang Y, Pan X, Ye J, Gan S, Qu F,
Chen L, Chu C, Gao Y and Cui X: Frizzled 8 promotes the cell
proliferation and metastasis of renal cell carcinoma. Oncotarget.
8:78989–79002. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang J, Pang W, Zuo Z, Zhang W and He W:
MicroRNA-520b suppresses proliferation, migration, and invasion of
spinal osteosarcoma cells via downregulation of frizzled-8. Oncol
Res. 25:1297–1304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Xu L, Wen T, Liu Z, Xu F, Yang L, Liu J,
Feng G and An G: MicroRNA-375 suppresses human colorectal cancer
metastasis by targeting frizzled 8. Oncotarget. 7:40644–40656.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Waks AG and Winer EP: Breast cancer
treatment: A review. JAMA. 321:288–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Bianchini G, De Angelis C, Licata L and
Gianni L: Treatment landscape of triple-negative breast
cancer-expanded options, evolving needs. Nat Rev Clin Oncol.
19:91–113. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kirikoshi H, Sekihara H and Katoh M:
Expression profiles of 10 members of frizzled gene family in human
gastric cancer. Int J Oncol. 19:767–771. 2001.PubMed/NCBI
|
|
64
|
Hu X, Zhang Q, Xing W and Wang W: Role of
microRNA/lncRNA intertwined with the Wnt/β-catenin axis in
regulating the pathogenesis of triple-negative breast cancer. Front
Pharmacol. 13:8149712022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wang Y, Chen L, Wu Z, Wang M, Jin F, Wang
N, Hu X, Liu Z, Zhang CY, Zen K, et al: miR-124-3p functions as a
tumor suppressor in breast cancer by targeting CBL. BMC Cancer.
16:8262016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Zhao X, Bai X, Li W, Gao X, Wang X and Li
B: microRNA-506-3p suppresses the proliferation of triple negative
breast cancer cells via targeting SNAI2. Mol Cell Toxicol.
17:513–522. 2021. View Article : Google Scholar
|
|
67
|
Zhang YF, Yu Y, Song WZ, Zhang RM, Jin S,
Bai JW, Kang HB, Wang X and Cao XC: miR-410-3p suppresses breast
cancer progression by targeting Snail. Oncol Rep. 36:480–486. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Long X, Shi Y, Ye P, Guo J, Zhou Q and
Tang Y: MicroRNA-99a suppresses breast cancer progression by
targeting FGFR3. Front Oncol. 9:14732020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lin S, Zhao M, Lv Y, Mao G, Ding S and
Peng F: The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor
prognosis of breast cancer via the PLK1 signaling pathway. Aging
(Albany NY). 13:13663–13679. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zou Y, Zheng S, Xiao W and Xie X, Yang A,
Gao G, Xiong Z, Xue Z, Tang H and Xie X: circRAD18 sponges
miR-208a/3164 to promote triple-negative breast cancer progression
through regulating IGF1 and FGF2 expression. Carcinogenesis.
40:1469–1479. 2019.PubMed/NCBI
|
|
71
|
Gujrati H, Ha S, Waseem M and Wang BD:
Downregulation of miR-99b-5p and upregulation of nuclear mTOR
cooperatively promotes the tumor aggressiveness and drug resistance
in African American prostate cancer. Int J Mol Sci. 23:96432022.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Gong Y, He T, Yang L, Yang G, Chen Y and
Zhang X: The role of miR-100 in regulating apoptosis of breast
cancer cells. Sci Rep. 5:116502015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wang W, Liu Y, Guo J, He H, Mi X, Chen C,
Xie J, Wang S, Wu P, Cao F, et al: miR-100 maintains phenotype of
tumor-associated macrophages by targeting mTOR to promote tumor
metastasis via Stat5a/IL-1ra pathway in mouse breast cancer.
Oncogenesis. 7:972018. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Assidi M, Buhmeida A, Al-Zahrani MH,
Al-Maghrabi J, Rasool M, Naseer MI, Alkhatabi H, Alrefaei AF, Zari
A, Elkhatib R, et al: The prognostic value of the developmental
gene FZD6 in young Saudi breast cancer patients: A biomarkers
discovery and cancer inducers OncoScreen approach. Front Mol
Biosci. 9:7837352022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zeng CM, Chen Z and Fu L: Frizzled
receptors as potential therapeutic targets in human cancers. Int J
Mol Sci. 19:15432018. View Article : Google Scholar : PubMed/NCBI
|
